Tag | Content |
---|
EnhancerAtlas ID | HS037-10298 |
Organism | Homo sapiens |
Tissue/cell | ESC |
Coordinate | chr13:51798950-51799800 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MAFK | MA0496.2 | chr13:51799361-51799380 | AGATGATGAATCAGCAGTT | + | 6.28 | MAFK | MA0496.2 | chr13:51799361-51799380 | AGATGATGAATCAGCAGTT | - | 6.39 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_04027 | chr13:51798456-51799442 | Brain_Anterior_Caudate | SE_04875 | chr13:51795173-51802160 | Brain_Cingulate_Gyrus | SE_05940 | chr13:51795204-51800077 | Brain_Hippocampus_Middle | SE_06773 | chr13:51795633-51802419 | Brain_Hippocampus_Middle_150 | SE_07855 | chr13:51796493-51800426 | Brain_Inferior_Temporal_Lobe |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH13I051224 | chr13 | 51798457 | 51799442 |
|
Enhancer Sequence | CCCTGACTCC TGTTATGGAG TCCCTTCTTC CCTCCCTGGC CTTGTTTCTC AGCAGGTCCT 60 TCTTTGCGCC TTGTATTTTT CTGTTTCCTC GCCTTTGTCA AGCTGCCCTC TTTGCCAGCT 120 CTGCCCTTCC CACCTGACTT GCCTGTCTGC CAGGTGAAAC TCTACTCTTC TTTCAGGACT 180 CAGCTCAAGT GACACATCTG CTAAGGCAGT GATCCTTAAT TTGGGGTCCA TGAATTCCTT 240 CAAGTTGTAT GCAAAATGAT GTGCTTTGTG AATTTGTATG AGAAGAGAAC TTTTTTTTTT 300 TATCAGATTC TCAAAGTAGC TGGTGATCTA TTCCAAACCA AGTTTGGGCA AGATATGAGA 360 CATTTCATTT TCAACACACT GTGTCTGAGG TGTTGCAAGA CATCCAAGTA AAGATGATGA 420 ATCAGCAGTT GGGTATATCT GTCTGGAACT CAGAAGGGAG GTCTTCATGA TGACATTGCA 480 TTTGGGTACT ATTTACCTAA AAATGGCAAT GGAAGCTCTG GGAGAGACTA AATCAACTGA 540 AGGTAATAGC AAGCACTTTC TTAGCATTTA GTATGTGCCA CCTACTGTTC TAAGCCTTTA 600 TGTATTTCAT GGACTCCTCG AATCCTTCAA CAACTCTGTG CAGCAGGTGC TTTTTAAGAC 660 CAGCCTTGAG AAACTATATT TAAACGCCCA GTCAATGAGA ATGAGCTGAT AAAGGAGCCT 720 GAGAAAGAGT AGACTTGGAG TCAAAGAAAG AAGAATATGA ATCATTGAAG CCAAGGGAGG 780 TTTGAGTTTT TGAGAAAGGA AGGAGAGATC AACTATGCTA CTGAGAAACT AATGAAGATG 840 AGGAACGCTA 850
|